Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer

Author： Cullen Kevin   Yang Zejia   Schumaker Lisa   Guo Zhongmin  

Publisher： Springer Publishing Company

ISSN： 0145-479X

Source： Journal of Bioenergetics and Biomembranes, Vol.39, Iss.1, 2007-02, pp. : 43-50

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

STAT3 as a therapeutic target in head and neck cancer

By Leeman Rebecca J   Lui Vivian Wai Yan   Grandis Jennifer Rubin  

Expert Opinion on Biological Therapy, Vol. 6, Iss. 3, 2006-03 ,pp. : 231-241

Informa Healthcare

Access to resources Recommend Favorite

Zalutumumab in head and neck cancer

By Schick Ulrike   Gujral Dorothy M   Richards Tom M   Harrington Kevin J   Nutting Christopher M  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 1, 2012-01 ,pp. : 119-125

Informa Healthcare

Access to resources Recommend Favorite

Immune alterations and immunotherapy prospects in head and neck cancer

By Varilla Vincent  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 9, 2013-09 ,pp. : 1241-1256

Informa Healthcare

Access to resources Recommend Favorite

Selenium and immunocompetence in patients with head and neck cancer

By Kiremidjian-Schumacher L.   Roy M.   Glickman R.   Schneider K.   Rothstein S.   Cooper J.   Hochster H.   Kim M.   Newman R.  

Biological Trace Element Research, Vol. 73, Iss. 2, 2000-02 ,pp. : 97-111

Humana Press, Inc

Access to resources Recommend Favorite

Genetic variations and head and neck cancer risks

By Masood Nosheen   Yasmin Azra   Kayani Mahmood  

Molecular Biology Reports, Vol. 41, Iss. 4, 2014-04 ,pp. : 2667-2670

Springer Publishing Company

Access to resources Recommend Favorite